Treatment with gemcitabine and an EGFR-inhibitor

Details for Australian Patent Application No. 2005249205 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Higgins, Brian; Kolinsky, Kenneth

Agent Davies Collison Cave

Pub. Number AU-A-2005249205

PCT Pub. Number WO2005/117887

Priority 60/576,541 03.06.04 US

Filing date 27 May 2005

Wipo publication date 15 December 2005

International Classifications

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/5377 (2006.01)

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/117887 Priority application(s): WO2005/117887

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249206-Treatment with cisplatin and an EGFRinhibitor

2005249204-Inactivation of a pathogen in a sample by a treatment with formalin and UV light